Company news

Sonoma Pharmaceuticals, Inc. news in 2021

Sonoma Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results

November 14, 2021

Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia

November 8, 2021

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time

October 14, 2021

Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe

September 27, 2021

Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland

August 18, 2021

Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results

August 15, 2021

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results

July 13, 2021

Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn®-based Rx Dermatology and Eye Care Products Nationwide

March 30, 2021

Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences

March 3, 2021

Sonoma Pharmaceuticals Reports Third Quarter FY 2021 Financial Results

February 15, 2021

Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and Thailand

January 27, 2021

Sonoma Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

January 10, 2021

Decks in 2021